Sinotherapeutics Revenue

In the year 2025, Sinotherapeutics had annual revenue of 446.57M CNY, down -12.71%. Sinotherapeutics had revenue of 115.10M in the quarter ending December 31, 2025, a decrease of -22.75%.

Revenue

446.57M

Revenue Growth

-12.71%

P/S Ratio

9.21

Revenue / Employee

1.43M

Employees

312

Market Cap

4.11B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	446.57M	-65.05M	-12.71%
Dec 31, 2024	511.62M	211.75M	70.61%
Dec 31, 2023	299.87M	52.31M	21.13%
Dec 31, 2022	247.56M	-67.91M	-21.53%
Dec 31, 2021	315.47M	-3.69M	-1.16%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
LanZhou Foci Pharmaceutical	915.53M
Shanghai Jiaoda Onlly Co.,Ltd	314.12M
Shanghai Xiao Fang Pharmaceutical	504.59M
Henan Taloph Pharmaceutical Stock Co.,Ltd	1.76B
Shanghai MicuRx Pharmaceutical	141.77M
Shandong Wohua Pharmaceutical	818.16M
Qianjiang Yongan Pharmaceutical	783.17M
Jinhe Biotechnology CO., LTD.	2.75B

Revenue Rankings